| Name | oteseconazole |
|---|---|
| Synonyms |
VHH774W97N
2-Pyridineethanol, α-(2,4-difluorophenyl)-β,β-difluoro-α-(1H-tetrazol-1-ylmethyl)-5-[4-(2,2,2-trifluoroethoxy)phenyl]-, (αR)- oteseconazole (2R)-2-(2,4-Difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-{5-[4-(2,2,2-trifluoroethoxy)phenyl]-2-pyridinyl}-2-propanol 10138 |
| Description | Oteseconazole (VT-1161) is an orally active anti-fungal agent, potently binds to and inhibits Candida albicans CYP51 (Kd, <39 nM), shows no obvious effect on human CYP51[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 609.2±65.0 °C at 760 mmHg |
| Molecular Formula | C23H16F7N5O2 |
| Molecular Weight | 527.394 |
| Flash Point | 322.3±34.3 °C |
| Exact Mass | 527.119202 |
| LogP | 5.70 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.570 |